Pancreatic Cancer Research

ResearcherYamagata UniversityActive in the last 2 years

Yuya Ashitomi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9600-1566; OpenAlex author ID A5007377344. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 2 papers

Papers 3

  1. Favorable Response Defined by CA19-9 Reduction After Neoadjuvant Treatment for Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18084-0↗
  2. ASO Author Reflections: How to Evaluate CA19-9 Response to Neoadjuvant Treatment for Resectable Pancreatic Cancer?: Reduced Value or Reduction Rate? First author DOI 10.1245/s10434-025-18169-w↗
  3. [Treatment Experience of Chemotherapy and Carbon-Ion Radiotherapy followed by Curative Conversion Surgery for Initially Locally Advanced Unresectable Pancreati… Co-author PMID 38303264↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fuyuhiko Motoi · 3 shared papers, 2023–2025 · strength 0.90
  2. So Yamaki · 1 shared paper, 2025 · strength 0.19
  3. Sohei Satoi · 1 shared paper, 2025 · strength 0.19
  4. Teiichi Sugiura · 1 shared paper, 2025 · strength 0.19
  5. Kenjiro Okada · 1 shared paper, 2025 · strength 0.19
  6. Masamichi Mizuma · 1 shared paper, 2025 · strength 0.19
  7. Atsushi Oba · 1 shared paper, 2025 · strength 0.19
  8. Kojiro Omiya · 1 shared paper, 2025 · strength 0.19
  9. Daisuke Hashimoto · 1 shared paper, 2025 · strength 0.19
  10. Kenichiro Uemura · 1 shared paper, 2025 · strength 0.19
  11. Katsuhisa Ohgi · 1 shared paper, 2025 · strength 0.19
  12. Koetsu Inoue · 1 shared paper, 2025 · strength 0.19
  13. Satoshi Hirano · 1 shared paper, 2025 · strength 0.19
  14. Hiroshi Watanabe · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.